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ABSTRACT
We have identified a putative transcription factor, designated hLim-1, from human fetal brain using degen¬
erate polymerase chain reaction (PCR) and cDNA library screening. The deduced open reading frame, de¬
rived from sequencing a 3.0-kb hLim-1 cDNA, encodes a protein of 384 amino acids with two cysteine-rich
LIM domains and one homeobox (HOX) DNA-binding domain. The nucleotide sequence of hLim-1 cDNA is
87% identical to mouse Lim-1 and the predicted amino acid sequence is greater than 97% conserved. Ex¬
pression patterns of hLim-1 were evaluated by Northern analysis and reverse transcription (RT)-PCR cou¬
pled with Southern blotting. HLim-1 expression was observed in human brain, thymus, and tonsillar tissue.
Expression of hLim-1 was also observed in 58% of acute myelogenous leukemia (AML) cell lines and in four
of five primary samples from patients with chronic myeloid leukemia (CML) in myeloid blast transforma¬
tion. The gene encoding hLim-1 was mapped using fluorescence in situ hybridization (FISH) to human chro¬
mosome 11
 
12— 13. The expression pattern and structural characteristics of the hLim-1 gene suggest that it
encodes a transcriptional regulatory protein involved in the control of differentiation and development of
neural and lymphoid cells. Its expression in CML in blast crisis suggests that it may be involved with pro¬
gression in this disease; a prospective study is required to confirm this.
INTRODUCTION 1992), mLim-1 (Barnes et al., 1994), rLH2 (Xu et al., 1993),
hLH2 (Wu et al, 1996), and mLim-3 (Seidel et al., 1994). Lin
Genes containing HOMEODOMAiNS play an important role 11 and mec3 are important in the determination of cell fate inin the growth and differentiation of the developing em- mechanosensory neurons and vulval cells, respectively. mLH2
bryo and the adult animal. The genes encoding homeodomain was first identified in developing  lymphocytes. The gene is
proteins may be broadly classed as either clustered or dispersed, expressed in early precursors and is absent from the mature
This latter group of homeotic genes can be further divided based progeny, suggesting a role in the differentiation of the cells (Xu
upon the presence of certain functional motifs in addition to the et al, 1993). LH2 is also expressed in pituitary cells and ap-
DNA-binding homeodomain; one such motif is the LIM do- pears to have a role in the regulation of expression of pituitary
main, first recognized in the Lin 11 gene of Caenorhabditis el- glycoprotein hormone a-subunit gene (Roberson et al., 1994).
egans (Freyd et al., 1990), isl-1 of mammalian cells (Karlsson mLIM3 is expressed in the neuroepithelium of embryos and in
et al, 1990), and mec-3 of C. elegans (Way and Chalfie, 1988). adult life it is expressed in the anterior and intermediate lobes
The LIM motif consists of cysteine-rich regions capable of com- of the pituitary. xLim-1 is predominantly expressed during du¬
plexing zinc and forming finger-like structures. These zinc fin- bryogenesis in the gastrula stage and in the adult is expressed
ger motifs have been shown to be involved in protein-protein in the brain (Taira et al, 1992). The murine homologue, mLim-
interactions; to date, there is no convincing evidence of DNA- 1, is predominantly expressed in the brain and kidney in the
binding activity. embryo and adult (Barnes et al, 1994).
Members of the LIM-hox family of genes that have been Using degenerate oligonucleotides, we identified the ex-
identified include Lin 11, isl-1, mec-3, xLim-1 (Taira et al., pression of mLim-1 in mouse fetal brain, liver and spleen. We
'Ontario Cancer Institute, Princess Margaret Hospital, Departments of Medicine, Medical Biophysics, and Institute of Medical Sciences, Uni¬
versity of Toronto, Canada, M5G 2M9.
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cloned mouse Lim-1 and used this as a probe to isolate the hu¬
man homologue. The gene is expressed in brain, tonsil, and thy¬
mus of adult humans. In addition, we found aberrant expres¬
sion of hLim-1 in a variety of human primary leukemias and
human leukemic cell lines. Human Lim-1 was mapped by flu¬
orescent in situ hybridization to chromosome band lip12-13.
bone marrow cells from a normal individual were depleted of
adherent cells by plastic adherence. The cells were then incu¬
bated on ice with fluoroisothiocyanate (FITC)-conjugated anti-
CD34 monoclonal antibody (Serotec, Quebec) for 1 hr. Five
times 105 CD34+ cells were then separated using fluorescence-
activated cell sorting (FACStar, Becton Dickinson, San Jose,
CA).
MATERIALS AND METHODS
Cell lines and patient samples
Peripheral blood or bone marrow was obtained from normal
individuals and from patients with leukemia following informed
consent. Mononuclear cells were isolated by Ficoll-Hypaque
centrifugation.  lymphocytes were removed from peripheral
blood samples by E-rosetting with sheep red blood cells fol¬
lowed by a second Ficoll-Hypaque centrifugation (Minden et
al, 1979). Cells were either used immediately to prepare RNA
and DNA or were stored in liquid nitrogen in  -minimal es¬
sential medium (MEM) containing 10% dimethylsulfoxide(DMSO) and 50% fetal calf serum (FCS). Trie cell lines eval¬
uated are listed in Table 1.
To prepare a CD34+ enriched cell population, mononuclear
RNA isolation
Total RNA was extracted from peripheral blood, bone mar¬
row, and the cell lines and from several different fetal mouse
tissues by a guanidinium thiocyanate-based method (Chirgwin
et al., 1979).
cDNA synthesis
Total RNA (1 µg) was added to a 20-µ. solution containing
40 mM Tris-HCl pH 8.3, 50 mM KC1, 5 mM dithiothreitol
(DTT), 2 mM MgCl2, 10 pM of random hexamer (Pharmacia),
2 µ of each deoxyribonucleotide triphosphate (dNTP), 1 µ\(40 units) of RNasin ribonuclease inhibitor (Promega Corp.,
Madison, WI) and 1 µ\ (100 units) of Moloney murine leukemia
virus reverse transcriptase (RT) (GIBCO-BRL, Canada). This
mixture was incubated at 37°C for 45 min.
Table 1. Expression of hLim-1 in Normal Cells and Malignant Cell Lines
Lineage hLim-1
Normal tissue
PB mononuclear cells
BM cells
CD341 cells
Brain
Placenta
Tonsil
Testis
Thymus
Cell line
OCI/AML-1
OCI/AML-2
OCIVAML-3
OCI/AML-4
OCI/AML-5
OCI/AML-6
KG-1
NB-4
U937
HEL
TF-1
M07E
K562
ALL-Sil
KOPKT-1
MKB-1
MOLT-16
HUT-78
OCI/Ly-13.1
OCI/Ly-13.2
OCI/Ly-8
A-172
HeLa
Mature  and  leukocytes
Developing hematopoietic tissue
BM progenitor cells
Nervous system
Fetal tissue
Lymphoid tissue
Reproductive tissue
Precursor T-lymphoid
Acute myelogenous leukemia
Acute myelogenous leukemia
Acute myelogenous leukemia
Acute myelogenous leukemia
Acute myelogenous leukemia
Acute myelogenous leukemia
Acute myelogenous leukemia
Acute promyelocytic leukemia
Acute monocytic leukemia
Erythroleukemia
Erythroleukemia
Megakaryoblastic leukemia
Chronic myelogenous leukemia myeloid blast crisis
T-cell lymphoblastic leukemia
T-cell lymphoblastic leukemia
T-cell lymphoblastic leukemia
T-cell lymphoblastic leukemia
Cutaneous T-cell lymphoma
T-cell lymphoma at presentation
T-cell lymphoma at relapse
B-cell lymphoma
Glioblastoma
Epitheliod carcinoma
+ + +
+ +
+ +
+ +
+ +
+ + +
+ + +
+
+ + +
+
+ + +
+ + +
(—) Not detectable; (+) weakly positive; (+ ++) strongly positive.
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Generation of mouse Lim-1 (mlim-1) probe by
PCR cloning
Total cell RNA extracted from fetal mouse brain, liver,
spleen, and thymus was reverse-transcribed into single-strand
cDNA as described above. cDNA was then mixed with two de¬
generate primers; 5'-(C/A)G(A/G)GGACC(T/A)(C/A)G(A/G)-
ACNACNAT-3' (primer A, sense strand corresponding to RG-
PRTTI and 5'-(A/G)TT(T/C)TGAAACCA(G/C)ACC(T/C)G-
3' (primer B, antisense strand corresponding to QVWFQN); the
location of the primers is shown in Fig. 1 A. The final reaction
volume was 100 µ , containing 0.2 mM of each dNTP, 2.5 mM
MgCl2, 50 mM KC1, 10 mM Tris-HCl pH 8.3, and 2.5 units of
Taq polymerase. The target domain was amplified using the
following conditions: two cycles at 94°C for 1 min, 37°C for
2 min, and 72°C for 1 min, followed by 30 cycles at 94°C for
1 min, 50°C for 1 min, and 72°C for 1 min. A final 10-min ex¬
tension at 72°C was added after the last cycle. The amplified
0.16-kb band was purified from an agarose gel and was cloned
into a TA cloning vector using blue/white selection (TA cloning
kit, Invitrogene). White colonies were picked and sequenced
using dideoxy sequencing. Sequence analysis and comparison
were done using the University of Wisconsin Genetics Com¬
puter Group programs. The clone containing the polymerase
chain reaction (PCR) fragment displaying the highest degree of
DNA sequence homology with Xlim-1 was purified and the
fragment was labeled to a high specific activity with [a-
32P]dCTP by random priming with hexanucleotides.
Human cDNA library screening
Plaques (106) of a human fetal brain cDNA library in the
Eco RI site of AZapII (Stratagene) were screened using the 0.16-
kb PCR fragment of mLim-1 as a random-primed probe.
Overnight hybridization was performed at 60°C in hybridiza¬
tion solution containing 4X SET, 0.1% sodium pyrophosphate,
0.2% NaDodS04, and 500 /xg/ml of heparin. The final wash¬
ing condition was 0.2X SSC, 0.1% NaDodS04 at 60°C for 20
min. In vivo excision of the positive clones was performed as
per the instructions from the manufacturer (Stratagene).
DNA sequencing of hLim-1 cDNA clone
DNA sequencing of the hLim-1 clone was carried out using
the Sanger dideoxy method with Sequenase, Version 2.0 (U.S.
Biochemicals). The universal M13 primers and four oligonu-
cleotides derived from sequences obtained from various sub-
clones of the 3.0-kb cDNA were used as primers. DNA se¬
quences and their corresponding amino acid sequences were
analyzed using the University of Wisconsin Genetics Computer
Group program. The sequence was deposited in GenBank (ac¬
cession #U14755).
Expression of hLim-1 detected by Northern blotting
and by RT-PCR coupled with Southern blotting
For Northern blotting, a commercially available human mul-
titissue blot (Stratagene) was used as a source of RNA and hy¬
bridized with the full-length hLim-1 cDNA as a random-primed
probe or with a random-labeled internal probe to /3-actin. Au-
toradiography was performed at —70°C for 12-48 hr using Ko¬
dak XAR film.
For detection of hLim-1 by reverse transcription (RT)-PCR
coupled with Southern blotting, 5µ\ of cDNA obtained from
RNA prepared from a variety of human tissue sources was mixed
in 100 µ\ of solution containing 10 mM Tris-HCl pH 8.3, 50 mM
KC1, 1.5 mM MgCl2, 0.4 µ of each dNTP, 10% dimethylsul-
foxide (DMSO) and 2.5 units of Taq polymerase. The hLim-1
-
specific oligonucleotide primers hLM715F (5'-AACAAG-
CAGCTCTCCACT-3', sense) and hLM1107R (5'-GACCTGA-
ATGACGCGCAT-3', antisense) were added at a final concen¬
tration of 50 pM. These primers correspond to the regions span¬
ning nucleotides 715-732 (hLM715F) and 1,093-1,110
(hLMlllOR) of hLim-1 cDNA. Reaction mixtures were ampli-
Ptoline rich region
 
GAATTCCCGGCGCTTTCCTCGCAACCCGAGCTCGGCGAGTCGTCGTCTTCTTCTTCTCCG
TTTTTATTTATTTATTTCCGTTCCCGCCGCCGTTCTCGCTGACCTTCACTCCTCCGCGGG
CTCTGAGCAGAAGGGTCGCATTCTCTCCCGCCTGAGACTTCTTTTCCTCGCCCCGGGAGC
TCAGGCGGCGCGCTCCAGCCCGGGGCCCCGGACTCCCCGGCTGCACACTTCACTGAGACG
CCCCCAGGCCCGATCAGCCTCGTTCTCCACCCTACTTTGATTTCCTGGTGCGAGTTTTGG
CTTGCACGGCCGAGTGTGTGTCCTCTTTTTGGAGAGACTGGGGAGCTCGTGCCGATTGTC
TTCAGGAGTCATCCCCTGGGCTCTACTTTGCCCCTCTCTCTCTCTGGGCCTCATCAGACC
AAACCAAAGACCATGGTTCACTGTGCCGGCTGCAAAAGGCCCATCCTGGACCGCTTTCTC
M V H CAGCKRPILDRFL
TTGAACGTGCTGGACAGGGCCTGGCACGTCAAGTGCGTCCAGTGCTGTGAATGTAAATGC
LNVLDRAWHVKCVQCCECKC
AACCTGACCGAGAAGTGCTTCTCCAGGGAAGGCAAACTCTACTGCAAGAACGACTTCTTC
NLTEKCFSREGKLYCKNDF F
CGGTGTTTCGGTACCAAATGCGCAGGCTGCCGTCAGGGCATCTCCCCTAGCGACCTGGTG
R C F G   CAGCRQGISPSDLV
CGGAGAGCGCGGAGCAAAGTGTTTCACCTGAACTGCTTCACCTGCATGATGTGTAACAAG
RRARSKVFHLNCFTCMMCNK
CAGCTCTCCACTGGCGAGGAACTCTACATCATCGACGAGAATAAGTTCGTCTGCAAAGAG
QLSTGEELYIIDENKFVCKE
GATTACCTAAGTAACÄGCAGTGTTGCCAAAGAGAACAGCCTTCACTCGGCCACCACGGGC
D_Y LSNSSVAKENSLHSATTG
AGTGACCCCAGTTTGTCTCCGGATTCCCAAGACCCGTCGCAGGACGACGCCAAGGACTCG
SDPSLSPDSQDPSQDDAKDS
GAGAGCGCCAACGTGTCGGÄCAAGGAAGCGGGTAGCAACGAGAATGACGACCAGAACCTG
ESANVSDKEAGSNENDDQNL
GGCGCCAAGCGGCGGGGACCCGGCACCACCATCAAAGCCAAGCAGCTGGAGACGCTGAAG
G A KRRGPGTTIKAKQLETLK
GCCGCCTTCGCTGCTACACCCAAGCCCACCCGCCACATCCGCGAGCAGCTGGCGCAGGAG
AAFAATPKPTRHIREQLAQE
ACCGGCCTCAACATGCGCGTCATTCAGGTCTGGTTCCAGAACCGGCGCTCCAAGGAGCGG
TGLNMRVIQVWFQNRRSKER
AGGATGAAGCAGCTGÄGCGCCCTGGCCGGCCACGCCTTCTTCCGCAGTCCGCGCCGGATG
R M  QLSALAGHAFFRSPRRM
CGGCCGCTGGTGGACCGCCTGGAGCCGGGCGAGCTCATCCCCAATGGTCCCTTCTCCTTC
RPLVDRLEPGELIPNGPFSF
TACGGAGATTACCAGAGCGAGTACTACGGGCCCGGGGGCAACTACGACTTCTTCCCGCAA
YGDYQSEYYGPGGNYDFFPQ
GGCCCCCCGTCCTCGCAGGCCCAGACACCAGTGGACCTACCCTTCGTGCCGTCATCTGGG
GPPSSQAQTPVDLPFVPSSG
CCGTCCGGGACGCCCCTGGGTGGCCTGGAGCACCCGCTGCCGGGCCACCACCCGTCGAGC
PSGTPLGGLEHPLPGHHPSS
GAGGCGCAGCGGTTTACCGACATCCTGGCGCACCCACCCGGGGACTCGCCCAGCCCCGAG
EAQRFTDILAHPPGDSPSPE
CCCAGCCTGCCCGGGCCTCTGCACTCCATGTCGGCCGAGGTCTTCGGACCCAGCCCGCCC
PSLPGPLHSMSAEVFGPSPP
TTCTCGTCGCTGTCGGTCAACGGTGGGGCGAGCTACGGAAACCACCTGTCCCACCCCCCC
FSSLSVNGGASYGNHLSHPP
GAAATGAACGAGGCGGCCGTGTGGTAGCGGGGTCTCGCACGGTCTGCGGAGTTCGTGGTT
EMNEAAVW*
GTACAGAAATGAACCTTTATTTAAGAAAAATAG
FIG. 1. A. Schematic representation of Lim-1 showing the
sites of the degenerate primers to the Hox domain (primer A
forward, primer  reverse). For the amino acids encoded by
these primers see Materials and Methods. The sites of the LIM
domains, homeodomain, and proline-rich region are shown.
715F and 1110R are the primers used for RT-PCR expression
studies. B. Nucleotide sequence and deduced amino acid se¬
quence of hLim-1 cDNA. The tandem copies of the LIM mo¬
tifs followed by the homeobox domain are underlined. The in¬
sertion site of the domain encoding the alternative transcript is
indicated by the bolded arrow.
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fied by PCR in standard fashion. Parallel experiments, which in¬
cluded primers specific for the /3-actin gene, were amplified in
similar fashion and served as controls. PCR products were trans¬
ferred onto a Hybond-N+ nylon membrane (Amersham,
Oakville, ON) using the procedure described by Southern (1975)
and hybridized, where appropriate, with either the full-length
hLim-1 cDNA as a random-primed probe or with a random-la¬
beled internal probe to the /3-actin PCR product. Autoradiogra-
phy was performed at
—
70°C for 12 hr using Kodak XAR film.
Samples were considered positive for hLim-1 expression if a
band of appropriate size (~0.4 kb) was observed by hybridiza¬
tion with the full-length hLim-1 cDNA. Samples were consid¬
ered to be negative if RT-PCR amplification of 5 µ of the cDNA
reaction mixture did not yield a band by hybridization whereas
a human /3-actin band of appropriate size (—0.5 kb) was visible
after gel electrophoresis and ethidium bromide staining.
Chromosome localization by fluorescence in situ
hybridization
Plaques (106) from a human genomic library made from a
leukemic sample were screened with a hLim-1 cDNA probe. A
hLim-1-specific phage clone containing a 16-kb insert was iden¬
tified and confirmed by hybridization with several hLim-1
oligonucleotides.
Lymphocytes isolated from human cord blood were cultured
in  -MEM containing 10% FCS and phytohemagglutinin (PHA)
at 37°C for 68-72 hr. Lymphocyte cultures were then treated
with bromodeoxyuridine (BrdU) (0.18 mg/ml; Sigma, St. Louis,
MO) to synchronize the cell population. The synchronized cells
were washed three times with serum-free medium to release the
block and recultured for 6 hr in  -MEM containing thymidine(2.5 ^g/ml; Sigma). Cells were harvested, and metaphase spreads
were prepared using standard procedures. The hLim-1-contain¬
ing phage clone was labeled with biotinylated dATP (BioNick,
GIBCO-BRL) at 15°C for 1 hr. Fluorescence in situ hybridiza¬
tion (FISH) was performed as previously described (Heng et al,
1992). Briefly, südes were baked at 55°C for 1 hr, and follow¬
ing RNase A treatment, the DNA was denatured in 70% for-
mamide in 2X SSC for 1 min at 70°C and then dehydrated with
ethanol. The biotinylated hLim-1 genomic probe was denatured
at 75°C for 5 min in a hybridization mix of 50% formamide,
2XSSC, and 10% dextran sulfate. After overnight hybridization,
the slides were washed and the signals were revealed by fluo-
rescein-labeled avidin (Oncor Inc., Canada) Chromosomes were
identified by staining with 4',6-diamidino-2-phenylindóle
(DAPI). Assignment of FISH mapping data with chromosomal
bands was achieved by superimposing FISH signals with DAPI-
banded chromosomes (Heng and Tsui, 1993).
RESULTS
Isolation and sequence of mLim-1 gene
At the time of initiation of our studies, the murine homolog
of XLim-1 had not been deduced. To screen a human cDNA li¬
brary, we generated a mLim-1 probe using XLim-1 as a tem¬
plate. RNA extracted from fetal mouse brain, liver, and spleen
was reverse transcribed and the cDNA was used for amplifica¬
tion by RT-PCR. Using the degenerate primers A and B, corre¬
sponding to the RGPRTTI and QVWFQN amino acid sequences
in the homeodomain of Xlim-1, respectively, a predicted prod¬
uct of 0.16-kb was amplified reproducibly (Fig. 1A). The puri¬
fied band was cloned into a plasmid vector and 20 clones se¬
quenced. Analysis revealed that two classes of sequences were
obtained. One sequence class, isolated from fetal brain and
spleen, displayed 82% homology with the Xlim-1 homeobox do¬
main, and was therefore named mLim-1. The other sequence
class, isolated from all three fetal tissues, showed homology with
a human a-fetoprotein gene enhancer binding protein gene, aF-
PEB, which encodes a zinc finger homeobox protein. Because
our primary interest is in identifying members of the LIM-Hox
family, this result was not pursued further.
Cloning, sequencing, and structure of hLim-1 cDNA
The mLim-1 fragment was used as a probe to screen a human
fetal brain cDNA library. A clone containing a 3.0-kb insert was
identified and 1.712-kb of the 5'-end was sequenced (Fig. IB).
The sequence, termed hLim-1, was deposited in GenBank (ac¬
cession no. U14755) and represents the human homolog of Xlim-
1. Figure 1 shows the nucleotide and deduced amino acid se¬
quences of this 1.712-kb cDNA. Overall, the nucleotide sequence
of the coding region displays 87% homology with mLim-1, 85%
homology with chicken Lim-1 (cLim-1 ), and 79% homology with
Xlim-1. The 5 ' untranslated region of hLim-1 is 432 bp in length.
It is of note that the first 220 bp of the 5' untranslated region is
70% identical with the mouse 5' untranslated region, whereas
there is no homology between these two sequences over the re¬
mainder of the 5' untranslated region. This conservation of se¬
quence suggests that there may be a regulatory function of the
5' untranslated sequences. The translated region extends from
nucleotides 433 to 1,643. A comparison of the nucleic acid se¬
quences of mLim-1 and hLim-1 was 87% similar; however, at
the amino acid level, the sequence was 97% identical (Fig. 2).
Like other Lim-hox genes, the Lim domain is ahead of the home¬
obox domain. The 3' untranslated region of hLim-1 is approxi¬
mately 1.3-kb in length; this has not been sequenced.
Gene expression
Expression of hLim-1 was evaluated first by Northern blot¬
ting using a commercially available human multitissue blot and
RNA extracted from two human leukemia cell lines. Expres¬
sion of hLim-1 was not detected in normal tissue; however, a
4.0-kb band corresponding to the full-length transcript was de¬
tected in RNA of the K562 cell line, a line derived from the
leukemic cells of a patient with chronic myeloid leukemia(CML) in myeloid blast transformation (Fig. 3).
The ability to detect hLim-1 expression was enhanced when
evaluated by RT-PCR coupled with Southern blotting of RNA
from normal tissues. RT-PCR products were observed in sam¬
ples from human brain, tonsil, and thymus, but not peripheral
blood mononuclear cells, normal bone marrow, or CD34+ bone
marrow cells, colon, testis, ovary, or placenta. In RNA from
brain and tonsil, there were two bands of 405 bp and 498 bp,
whereas in thymus only the smaller band was present (Fig. 4).
To identify the nature of the 405- and 498-bp bands, both
were cloned and sequenced. The 405-bp band has a sequence
identical to the cDNA isolated from the brain cDNA library.
The 498-bp fragment was identical to the 405-bp band except
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I I I I I I I I I I I I I I I I I I I I I I i I I ! I I ! I I I I I I I I I I I
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I IIII I I I I IIII I I ti IIII I I I I I I IIII I I I I I I II
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KCFSREGKLYCKNDFFRCFGTKCAGCRQGISPSDLVRRAR 80
   M 1
   M M ! I I 1 I I 1 I I ! Il 11111 ! 1111 I 11
KCFSREGKLYCKNDFFRCFGTKCAGCAQGISPSDLVRRAR
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KCFSREGKLYCKNDFFRRFGTKCAGCAQGISPSDLVRRAR
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VSDKEAGSNENDDQNLGAKRRGPGTTIKAKQLETLKAAFA 200
I I II I III II II II I I I I I I I I I I I I I II I I I I I I I I I
VSDKEGGSNENDDQNLGAKRRGPRTTIKAKQLETLKAAFA
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LSALGARRHAFFRSPRRMRPLVDRLEPGELIPNGPFAFYG
DYQSEYYGPGGNYDFFPQGPPSSQAQTPVDLPFVPSSGPS 320
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DYQSEYYGPGGNYDFFPQGPPSSQAQTPVDLPFVPSSGPS
IIII II IIII IIIIIII I I I I I I I I I I I I I I I I I I I I
DYQSEYYGPGSNYDFFPQGPPSSQAQTPVDLPFVPSSVPA
GTPLGGLEHPLPGHH.PSSEAQRFTDILAHPPGDSPSPEP 360
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GTPLGGLDHPLPGHHAPSSEAQRFTDILAHPPGDSPSPEP
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SLPGPLHSMSAEVFGPSPPFSSLSVNGGASYGNHLSHPPE 400
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
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FIG. 3. Northern analysis of the hLim-1 gene transcript us¬
ing a human multitissue blot (Clontech) and mRNA from two
leukemia cell lines, K562 and NB-4. For the cell lines, 2 µg of
poly(A)+ RNA was used. Size makers are indicated on the left.
The sizes of the transcripts were determined by the relative po¬
sition of the 28S and 18S ribosomal bands of co-electrophoresed
total RNA.
The finding of hLim-1 expression in a human leukemia cell
line but not in normal  cells or CD34+ bone marrow cells
prompted a more extensive evaluation of hLim-1 expression in
a variety of human leukemias using established cell lines and
primary patient samples (Tables 1 and 2). Variable expression
was seen in the cell lines. Overall, 8 of the 21 (38%) different
leukemia/lymphoma cell lines showed expression of hLim-1.
Interestingly, 4 of 7 (57%) acute myelogenous leukemia (AML)
cell lines evaluated displayed hLim-1 expression. Both isoforms
were expressed in the cell lines, with the exception of KOPKT-
1, a cell line derived from an acute T-cell leukemia, which ex-
human:
xenopus
MNEAAVW
I I I I I I I
MNEAAVW
III III
MNETAVW
FIG. 2. Amino acid sequence alignment of XLim-1, mLim-
1, and hLim-1. Vertical bars indicate identical residues.
for a 93-bp insert beginning at nucleotide 829; the insert main¬
tains the reading frame (Fig. 5). To determine the genomic
structure responsible for these two forms, we performed PCR
on normal DNA using the same two primers. This resulted in
the amplification of a 498-bp piece. Inspection of this sequence
revealed potential splice donor sites of GGGT beginning at po¬
sition 828 of the full-length cDNA and a potential splice ac¬
ceptor of AGCC 93 bp downstream. Because the PCR primers
used in the RT-PCR experiments are potentially in the same
exon, we confirmed that the larger 498-bp RT-PCR product was
derived from RNA and not genomic DNA by treating samples
with RNase or DNase. Pretreatment of the samples with RNase
eliminated both bands. Pretreatment of the samples with DNase
did not alter the result, thus indicating that the RT-PCR prod¬
uct is derived from RNA and not DNA.
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FIG. 4. RT-PCR coupled with Southern blotting to detect
hLim-1 expression. cDNA prepared from the tissue and cell
populations indicated were amplified as outlined in Materials
and Methods. Specific amplification of hLim-1 was performed
using the hLM715F and hLMlllOR oligoprimers. A plasmid
containing hLim-1 cDNA and normal human genomic DNA
were used as positive control samples. The lane indicated as
negative contained no template DNA.
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FIG. 5. Sequence analysis of the large isoform of hLim-1. RT-
PCR using cDNA from tonsil was performed, and the large iso-
form was sequenced after isolation from an agarose gel. The nu¬
cleotide sequence and its deduced amino acid sequence are shown.
The uppercase letters represent the 93-bp insert; the deduced
amino acid sequence is shown below and is underlined. The ver¬
tical arrows show the boundaries of the additional sequences.
pressed only the smaller isoform. In contrast, none of the 13
samples from patients with AML and only 1 of 9 chronic-phase
CML patient samples expressed hLim-1 RNA (Table 2). Of
note, however, was the finding of hLim-1 expression in four of
five samples obtained from patients with CML in myeloid blast
transformation.
Chromosome mapping of hLim-1 by FISH
FISH, using the 16-kb hLim-1 containing phage DNA clone
as a labeled probe, revealed exclusive labeling to chromosome
11 (Fig. 6A,B). A total of 15 metaphase spreads were scored,
of which 10 were photographed. Signals were assigned to
11 pi 2-13 (Fig. 6C).
pression in cerebellum, medulla, and kidney and very low lev¬
els in cerebrum. They did not test thymus or tonsil, although
spleen was negative by this method for mLim-1 expression. We
used the more sensitive RT-PCR method to detect hLim-1 ex¬
pression in adult human tissues. High levels of expression were
found in brain, thymus, and tonsil; the other tested tissues were
negative. We did not test expression in human kidney. It is of
note that hLim-1 is expressed in a hierarchical manner in the
T-cell lineage because cells from the thymus were positive,
whereas peripheral blood mononuclear cells, composed pri¬
marily of mature  cells, were negative. This pattern of re¬
stricted expression is in keeping with other LIM-class home¬
obox genes thus far described. In the adult mouse, the restricted
pattern of mLim-1 expression suggests a role in the mainte¬
nance of differentiated renal tissue and in the maintenance of
differentiated cell populations within the central nervous sys¬
tem (CNS) (Barnes et al, 1994). Likewise, the expression pat¬
tern of LH-2, another mammalian LIM/homeobox gene, sug¬
gests that this protein may serve as a transcription factor
involved in the differentiation of distinct B- and T-cell sub-
populations (Xu et al, 1993).
The inability to detect hLim-1 expression in normal tissue
by Northern blotting, but its detection in selected tissue by RT-
Table 2. Expression of hLim-1
in Primary Leukemia Samples
DISCUSSION
In this study, we report the cloning, expression, and chro¬
mosomal localization of hLim-1, the proposed human homolog
of mLim-1 and XLim-1. The evidence that hLim-1 is, in fact,
the homolog of the above-mentioned genes is convincing. The
cDNA nucleotide sequence of the coding region of hLim-1 is
87% and 79% identical with mLim-1 and XLim-1, respectively.
Moreover, the deduced amino acid sequence of hLim-1 is 97%
identical with mLim-1. Furthermore, the LIM and home-
odomains of these proteins are even more highly conserved.
The amino acid sequence identity of these domains is greater
than 99% identical amongst hLim-1, mLim-1, and XLim-1.
This conservation suggests that a precise structural organiza¬
tion is required for the execution of the biological function(s)
of LIM motifs and homeodomains. Finally, the carboxy-termi-
nal portion of hLim-1 resembles that of mLim-1 and XLim-1
in being proline-rich, whereas, this region is glutamine-rich in
proteins encoded by many other LIM-class homeobox genes.
Like all known LIM-class homeobox genes, hLim-1 encodes
a protein with two tandemly repeated cysteine-rich LIM do¬
mains upstream of the homeodomain. The unique structural fea¬
ture of this human homolog, however, is that it encodes two
isoforms. The larger isoform has an additional 93 bp inserted
between the LIM domains and the homeodomain. These two
different forms arise as a result of alternative splicing. The ad¬
ditional sequences in the RNA results in the in-frame addition
of 31 amino acids in the region between the distal LIM domain
and the homeobox domain. Whether this insert has any func¬
tional significance is not known.
Barnes et al used RNase protection to evaluate the expres¬
sion of mLim-1 in adult tissues. They found high levels of ex-
Diagnosis Clinical Status hLim-1
AML-M1
AML-M2
AML-M2
AML-M2
AML-M2
AML-M4
AML-M4
AML-M4
AML-M4
AML-M4
AML-M5
AML-M7
AML-M7
CML-CP
CML-CP
CML-CP
CML-CP
CML-CP
CML-CP
CML-CP
CML-CP
CML-CP
CML-BP
CML-BP
CML-BP
CML-BP
CML-BP
Presentation
Presentation
Presentation
Presentation
Relapse
Presentation
Presentation
Presentation
Relapse
Relapse
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
Presentation
+ +
+ +
+ +
+ +
AML is classified using the FAB (French-American-British)
classification.
CML is classified using the NCI criteria: CP denotes first
chronic phase and BC denotes blast crisis. The symbol
—
represents no detectable hLim-1 expression, + represents weak
positive, and + + + represents strongly positive.
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15.4
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15.2
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13
11.22
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FIG. 6. A. hLIM-1 gene mapped to human chromosome band 1 lpl2—13 using FISH biotinated hLim-1 genomic phage DNA.
The biotinylated probe was hybridized to metaphasic chromosomes of normal human lymphocytes and detected with fluorescein-
labeled avidin. Fluorescent signals are indicated by arrows. B. Visualization of chromosome banding with staining with 4,6-di-
amidino-2-phenylindole (DAPI). C. Ideogram of human chromosome 11 showing the location of hLIM-1 gene. Each dot repre¬
sents the location of a double-fluorescent signal on chromosome 11.
PCR indicates that hLim-1 is expressed at relatively low lev¬
els. In contrast, some malignant cells overexpress hLim-1, as
shown by our detection using Northern blotting of hLim-1 tran¬
scripts in the K562 cell line. The aberrant expression of pro¬
teins containing LIM and/or Hox domains has been previously
shown to be implicated in the genesis of leukemias. The RBTN-
2 gene, which encodes a LIM-domain protein, was originally
identified by its involvement in a recurrent chromosomal
translocation in T-cell acute lymphoblastic leukemia (ALL) and
subsequently its overexpression has been shown to have trans¬
forming activity in transgenic mice (Fisch et al, 1992). Hox
genes have also been implicated in the development of leukemia
as a result of chromosomal translocations and activation by
retroviral insertion (Perkins et al, 1990; Kennedy et al, 1991).
The finding of hLim-1 overexpression in K562, coupled with
the observation of hLim-1 expression in lymphoid tissue and
precursor  cells, led to a more extensive evaluation of its ex¬
pression profile in a variety of hemato-lymphoid tumor cell
lines and in primary leukemia samples. Overall, hLim-1 ex¬
pression in human leukemia and lymphoma cell lines was vari¬
able, but with a preponderance in AML cell lines. We believe
that the finding of hLim-1 expression in AML cell lines is sig¬
nificant, because a relatively pure population of CD34+ nor¬
mal bone marrow cells, the postulated normal counterpart of
leukemia cells of myeloid origin, did not express hLim-1. Inter¬
estingly, hLim-1 expression was not detected in the evaluation
of primary AML samples; this is similar to our findings of hLH2,
another Lim/Hox gene (Wu et al, 1996). The inability to detect
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hLim-1 in primary AML samples may be because the gene is ex¬
pressed at very low levels in a minor population of cells; it has
been estimated that on the order of 1 in 104 to 1 in 105 cells are
able to establish leukemia in immune-deficient severe combined
immunodeficient (SCID) mice (Lapidot et al., 1994). Alterna¬
tively, the activation of hLim-1 in cell lines may be an artefact,
resulting from the growth in culture of the cells. A direct com¬
parison of RNA from the sample used to establish the cell line
is required to address this issue. Evidence that hLim-1 is involved
in leukemia in patients is provided by the finding of hLim-1 ex¬
pression in the blasts of patients with CML in blast crisis. The
presence of hLim-1 in CML blast crisis, but not in AML, further
confirms the uniqueness of these two conditions. The importance
of hLim-1 in the transition from chronic phase to blast crisis is
not known. Regardless of the importance of hLim-1 in transfor¬
mation, it may prove to be a useful marker for identifying pa¬
tients whose disease is entering the blast phase.
Finally, we mapped the hLim-1 gene to chromosome band
1 lpl2—13 by FISH. Region llpl2 has not been linked to any
diseases, but 1 lpl3 contains several important genes such as the
Wilm's tumor (WT) gene and RBTN-2 (Champagne et al., 1989;
Rose et al., 1990; Boehm et al., 1991). In the mouse, mLim-1
has been mapped to chromosome 11 by restriction fragment
length polymorphism and linkage analysis, yet in this animal the
WT gene and RBTN-2 reside on chromosome 2. This observa¬
tion suggests that the human chromosome 1 lp region containing
hLim-1 and the mouse chromosome domain that contains mLim-
1 are regions of synteny. However, more markers around the
hLim-1 locus are needed to confirm the relationship.
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